Ohlsson B

No ORCID on file · 17 papers in corpus · active 2007-2026

Study types

  • article 6
  • other 4
  • review 1

Condition tags

  • endometriosis 11
  • irritable_bowel_syndrome 9
2026
Experimental and therapeutic medicine ·doi:10.3892/etm.2026.13116

Bowel and skin biopsies from patients with gastrointestinal disorders have revealed neuropathic changes and altered connective tissue. Patients with postural orthostatic tachycardia syndrome (POTS) often suffer from gastrointestinal symptom…

other 2025
BMC gastroenterology ·doi:10.1186/s12876-025-04379-9

OBJECTIVES: Endometriosis and Irritable bowel syndrome (IBS) are two common diseases with overlapping symptomatology, causing confusion and delay in the diagnostic process. The objective of this study was to identify differences between end…

article 2025
Frontiers in medicine ·doi:10.3389/fmed.2025.1612079

BACKGROUND: Endometriosis can cause gastrointestinal symptoms that sometimes lead to incorrect diagnosis of irritable bowel syndrome (IBS). Receptors of thyroid-stimulating hormone (TSH) are found in the endometrium and are overexpressed in…

article 2023
BMC gastroenterology ·doi:10.1186/s12876-023-02861-w

BACKGROUND: Endometriosis and irritable bowel syndrome (IBS) have similar symptoms, pathogenesis, and risk factors. These diagnoses often coexist and are frequently misdiagnosed leading to diagnostic delays. This study of a population-based…

article 2022
BMC women's health ·doi:10.1186/s12905-022-01788-w

BACKGROUND: Risk prediction is an essential part of preventative medicine and in recent years genomic information has become an interesting factor in risk models. Polygenic risk scores (PRS) combine the effect of many genetic variations int…

article 2022
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2022.09.013

OBJECTIVES: The prevalence of several autoimmune diseases, including thyroid dysfunction, has been reported to be increased in patients with endometriosis. Upregulated thyroid stimulation hormone (TSH) receptors in ectopic endometrium and e…

other 2021
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology ·doi:10.5152/tjg.2020.19583

BACKGROUND: Gastrointestinal (GI) symptoms similar to irritable bowel syndrome (IBS) are often present in women with endometriosis and microscopic colitis (MC). The objective of this study was to estimate GI symptoms in IBS, endometriosis, …

article 2020
Biomedical reports ·doi:10.3892/br.2020.1282

The cytoplasmic protein AXIN1 is involved in the Wnt signalling pathway and its expression is increased in patients with endometriosis compared with healthy controls. The aim of the present cross-sectional study was to further assess the le…

other 2019
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2019.05.040

OBJECTIVES: Gastrointestinal symptoms are common in endometriosis, but the mechanisms behind these symptoms are yet poorly understood. Associations between endometriosis and irritable bowel syndrome (IBS), celiac disease, and various autoim…

review 2017
Frontiers in endocrinology ·doi:10.3389/fendo.2017.00110

Gonadotropin-releasing hormone (GnRH), follicle-stimulating hormone, and luteinizing hormone orchestrate the reproduction cycle and regulate the sex steroid secretion from the gonads. In mammals, GnRH1 is secreted as a hormone from the hypo…

article 2015
BMC women's health ·doi:10.1186/s12905-015-0213-2

BACKGROUND: Women with endometriosis often experience gastrointestinal symptoms. Gonadotropin-releasing hormone (GnRH) analogs are used to treat endometriosis; however, some patients develop gastrointestinal dysmotility following this treat…

other 2015
Scandinavian journal of gastroenterology ·doi:10.3109/00365521.2014.958098

BACKGROUND: Sporadic cases of abdominal pain and dysmotility has been described after treatment with gonadotropin-releasing hormone (GnRH) analogs. The aim of the present study was to scrutinize for patients with severe gastrointestinal com…

2014
Drug target insights ·doi:10.4137/dti.s19352

Gonadotropin-releasing hormone (GnRH) 1 and 2 and luteinizing hormone (LH) receptors have been described in the gastrointestinal tract. We have previously demonstrated antibodies in serum against GnRH1 in patients with gastrointestinal dysf…

2013
BMC pregnancy and childbirth ·doi:10.1186/1471-2393-13-201

BackgroundPrior reports suggest a link between gonadotropin-releasing hormone (GnRH) and gastrointestinal function. The aim of the study was to prospectively investigate women subjected to in vitro fertilization (IVF) using the GnRH analog …

2013
PloS one ·doi:10.1371/journal.pone.0066088

BackgroundMicroscopic colitis (MC) is a disease manifested by diarrhoea and is divided into collagenous and lymphocytic colitis. The aetiology is unknown, but auto-immunity is suggested. Auto-antibodies have been only rarely examined in thi…

2012
Drug target insights ·doi:10.33393/dti.2012.2403

Leuprolide is a gonadotropin-releasing hormone (GnRH) analog which has been shown to reduce symptoms in patients with irritable bowel syndrome (IBS) and chronic intestinal pseudo-obstruction (CIPO). The mechanism is not known, but one hypot…

2007
Drug target insights

Our understanding of the physiology of digestion, absorption, secretion, and motility in the gastrointestinal tract has improved immensely. Today it is well established that the gross functions of the gastrointestinal tract depend on the co…